United States Prosthetic Heart Valves Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast To 2020 GlobalData's new report, "United States Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the United States Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Prosthetic Heart Valves market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Read Complete Report with TOC: http://www.radiantinsights.com/research/united-statesprosthetic-heart-valves-market-outlook-to-2020 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Prosthetic Heart Valves categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves market. - Key players covered include Edwards Lifesciences Corporation, Medtronic, Inc., St. Jude Medical, Inc., Sorin Group and CryoLife, Inc. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 7 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/unitedstates-prosthetic-heart-valves-market-outlook-to-2020#tabs-4 2 Introduction 8 2.1 What Is This Report About? 8 2.2 Prosthetic Heart Valves Market Segmentation 8 2.3 Definitions of Markets Covered in the Report 9 3 Prosthetic Heart Valves Market, United States 10 3.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2005-2012 10 3.2 Prosthetic Heart Valves Market, United States, Revenue ($m), 2012-2020 12 3.2.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 14 3.2.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 16 3.2.3 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 18 3.2.4 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 20 3.3 Prosthetic Heart Valves Market, United States, Volume (Units), 2005-2012 22 3.4 Prosthetic Heart Valves Market, United States, Volume (Units), 2012-2020 24 3.4.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 26 3.4.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 28 3.4.3 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 30 3.4.4 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 32
3.5 Prosthetic Heart Valves Market, United States, Average Price ($), 2005-2020 34 3.6 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 20112012 36 3.7 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2011-2012 37 4 Overview of Key Companies in United States, Prosthetic Heart Valves Market 39 4.1 Edwards Lifesciences Corporation 39 4.1.1 Company Overview 39 4.2 Medtronic, Inc. 39 4.2.1 Company Overview 39 4.3 St. Jude Medical, Inc. 39 4.3.1 Company Overview 39 4.4 Sorin S.p.A. 40 4.4.1 Company Overview 40 5 Prosthetic Heart Valves Market Pipeline Products 41 6 Financial Deals Landscape 42 6.1 Debt Offerings 42 6.1.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 42 6.1.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 44 6.1.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 46 6.1.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 48 6.1.5 Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 50 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 6.1.6 St. Jude Medical Completes Public Offering Of Notes Due 2023 For US$900 Million 52 6.1.7 St. Jude Medical Completes Public Offering Of Notes Due 2043 For US$700 Million 54 6.1.8 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 56 6.1.9 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 58 6.1.10 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 60 6.2 Partnerships 62 6.2.1 NeoChord Enters Into Licensing Agreement With Robarts Research Institute 62 6.3 Venture Financing 63 6.3.1 CorMatrix Cardiovascular Raises US$0.25 Million In Venture Financing 63 6.3.2 Cardiaq Valve Technologies Raises US$32.5 Million In Venture Financing 64 7 Recent Developments 65 7.1 Corporate Communications 65 7.1.1 Apr 08, 2014: CardiAQ Valve Technologies appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs 65
7.1.2 Jan 28, 2014: St. Jude Medical Announces Organizational and Executive Leadership Changes 65 7.1.3 Jan 07, 2014: Simbionix Welcomes New Latin and Central American Sales Manager 66 7.1.4 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 66 7.1.5 Dec 05, 2013: Edwards Lifesciences Announces Appointment of CFO 68 7.1.6 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 69 7.1.7 Aug 13, 2013: Covidien launches Barrx Channel RFA Endoscopic Catheter 69 7.1.8 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 70 7.1.9 Jul 22, 2013: St. Jude Medical Appoints Stefan Widensohler to Its Board of Directors 71 7.1.10 Jul 03, 2013: Novartis Files Patent Infringement Lawsuit Against Intas Pharma Over Generic Myfortic 71 7.1.11 May 14, 2013: Edwards Lifesciences CFO Thomas M Abate To Retire 72 7.1.12 May 08, 2013: Cardio3 BioSciences Raises US$9 Million In Series D Financing 72 7.2 Financial Announcements 74 To Get More Details @ http://www.radiantinsights.com/research/united-states-prostheticheart-valves-market-outlook-to-2020 7.2.1 Apr 24, 2014: Edwards Lifesciences Reports Strong First Quarter Results 74 7.2.2 Apr 16, 2014: St. Jude Medical Reports First Quarter 2014 Results 75 7.2.3 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 77 7.2.4 Feb 03, 2014: Edwards Lifesciences Reports Strong Fourth Quarter Results 79 7.2.5 Jan 22, 2014: St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results 81 7.2.6 Dec 09, 2013: St. Jude Medical Announces Fourth Quarter Dividend 83 7.2.7 Nov 26, 2013: FDA approves Varithena (polidocanol injectable foam) for the treatment of patients with varicose veins 83 7.2.8 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 84 7.2.9 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 86 7.2.10 Oct 28, 2013: Edwards Lifesciences Reports Solid Third Quarter Results 86 7.2.11 Oct 16, 2013: St. Jude Medical Reports Third Quarter 2013 Results 88 7.2.12 Oct 02, 2013: St. Jude Medical Announces Third Quarter 2013 Earnings Conference Call 90 7.2.13 Aug 20, 2013: Medtronic Reports First Quarter Earnings 90 7.2.14 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 92 7.2.15 Jul 30, 2013: Teleflex subsidiary receives 510(k) clearance for balloon dilatation catheters 92 7.2.16 Jul 30, 2013: St. Jude Medical Announces Third Quarter Dividend 93 7.2.17 Jul 25, 2013: Edwards Lifesciences Reports Solid Second Quarter Results 94 7.2.18 Jul 17, 2013: St. Jude Medical Reports Second Quarter 2013 Results 95 7.2.19 Jul 11, 2013: Edwards Lifesciences to Host Earnings Conference Call on July 25, 2013 97
7.2.20 Jul 02, 2013: St. Jude Medical Announces Second Quarter 2013 Earnings Conference Call 97 7.2.21 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 97 7.2.22 May 10, 2013: New Excimer Laser from ZEISS for Refractive Surgery Reduces Treatment Time to the Benefit Both Doctor and Patient 99 7.3 Government and Public Interest 101 7.3.1 Mar 11, 2014: Simbionix Provides Comprehensive Virtual Reality Training for the Fast Arthroscopy Curriculum 101 7.3.2 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 101 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com